Technical Analysis for CMPI - Checkmate Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.23 0.28% 0.02
CMPI closed up 0.28 percent on Thursday, May 6, 2021, on 42 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Up
Historical CMPI trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish 0.28%
Narrow Range Bar Range Contraction 0.28%
NR7 Range Contraction 0.28%
Wide Bands Range Expansion 0.28%
Fell Below 20 DMA Bearish -1.50%
Older End-of-Day Signals for CMPI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 16 hours ago
60 Minute Opening Range Breakdown about 19 hours ago
60 Minute Opening Range Breakout about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
Up 1% about 20 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Checkmate Pharmaceuticals, Inc., a biotechnology company, develops novel immunotherapies for the treatment of cancer. It engages in the field of CpG oligonucleotides and validates an approach that combines the ability of CpG DNA to activate an anti-tumor T-cell response with checkpoint inhibition to overcome a tumor's ability to mute the immune response. The company has strategic alliances with Merck KGaA and Pfizer. Checkmate Pharmaceuticals, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Pharmaceutical Industry Immune System Immunotherapy Treatment Of Cancer Cancer Immunotherapy Virotherapy Tumor Immunotherapies Immune Response Oligonucleotide Checkpoint Inhibitor Nucleotides

Is CMPI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.1
52 Week Low 5.84
Average Volume 62,248
200-Day Moving Average 0.00
50-Day Moving Average 10.81
20-Day Moving Average 7.06
10-Day Moving Average 6.86
Average True Range 0.72
ADX 43.69
+DI 17.79
-DI 28.05
Chandelier Exit (Long, 3 ATRs ) 9.82
Chandelier Exit (Short, 3 ATRs ) 7.99
Upper Bollinger Band 9.02
Lower Bollinger Band 5.10
Percent B (%b) 0.54
BandWidth 55.49
MACD Line -1.03
MACD Signal Line -1.36
MACD Histogram 0.3215
Fundamentals Value
Market Cap 155.81 Million
Num Shares 21.6 Million
EPS
Price-to-Sales 0.00
Price-to-Book 1.85
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.48
Resistance 3 (R3) 7.48 7.40 7.44
Resistance 2 (R2) 7.40 7.33 7.40 7.42
Resistance 1 (R1) 7.31 7.29 7.27 7.31 7.41
Pivot Point 7.23 7.23 7.21 7.23 7.23
Support 1 (S1) 7.15 7.17 7.11 7.15 7.05
Support 2 (S2) 7.07 7.13 7.07 7.04
Support 3 (S3) 6.98 7.07 7.02
Support 4 (S4) 6.98